Close
Nordic 9Nordic 9

Fidat Ventures (investor - Venture Capital)

France
See something wrong or missing? Let us know
Offices:Paris
Average round investment:20.81M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: France Axoltis Pharma
Mostly invests in: France France (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fidat Ventures

Name Criteria
United States KB Partners
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States SeedInvest
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France BOLD - Business Opportunities for L'Oréal Development
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Simba Santé
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Singapore Genesis MedTech Group
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada adMare BioInnovations
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Boom Capital
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States BioMotiv
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Dominique Ferst
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Salamander Investment Network
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top